The neutrophil/lymphocyte ratio is an independent prognostic indicator in patients with bone metastasis

Oncology Letters

Volumn 2, Issue 4, 2011, Pages 735-740

  Shouyu, Wang ^a   Zhen, Zhang ^a   Fang, Fengqi ^a   Xue, Gao ^a   Wei, Sun ^a   Huanran, Liu ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Bone metastasis; Neutrophil lymphocyte ratio; Prognostic

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER PATIENT; COHORT ANALYSIS; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; FEMALE; HAZARD RATIO; HUMAN; LUNG CANCER; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEUTROPHIL; PREOPERATIVE EVALUATION; PROGNOSIS; PROSPECTIVE STUDY; THYROID CANCER; UTERUS CANCER;

EID: 79958023302     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2011.304     Document Type: Article

References (24)

1. Mundy GR: Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2: 584-293, 2002.
2. Coleman RE and Rubens RD: The clinical course of bone metastases from breast cancer. Br J Cancer 55: 61-66, 1987.
3. Wingo PA, Tong T and Bolden S: Cancer statistics. Cancer J Clin 45: 8-30, 1995.
4. Liu H, Liu G, Bao Q, et al: The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in rectal carcinoma. J Gastrointest Cancer 41: 116-120, 2010.
5. Yamanaka T, Matsumoto S, Teramukai S, Ishiwata R, Nagai Y and Fukushima M: The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer. Oncology 73: 215-220, 2007.
6. Coussens LM and Werb Z: Inflammation and cancer. Nature 420: 860-867, 2002.
7. Satomi A, Murakami S, Ishida K, Mastuki M, Hashimoto T and Sonoda M: Significance of increased neutrophils in patients with advanced colorectal cancer. Acta Oncol 34: 69-73, 1995.
8. Walsh SR, Cook EJ, Goulder F, Justin TA and Keeling NJ: Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 91: 181-184, 2005.
9. Liu H, Tabuchi T, Takemura A, et al: The granulocyte/lymphocyte ratio as an independent predictor of tumor growth, metastasis and progression: its clinical applications. Mol Med Rep 1: 699-704, 2008.
10. Atzpodien J, Royston P, Wandert T and Reitz M: Metastatic renal carcinoma comprehensive prognostic system. Br J Cancer 88: 348-353, 2003.
11. Négrier S, Escudier B, Gomez F, et al: Prognostic factors of survival and rapid progression in 782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Francais d'Immunothérapie. Ann Oncol 13: 1460-1468, 2002.
12. Donskov F and von der maase H: Impact of immune parameters on long-term survival in metastatic renal cell carcinoma. J Clin Oncol 24: 1997-2005, 2006.
13. Schmidt H, Suciu S, Punt CJ, et al: Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American Joint Committee on Cancer Stage IV Melanoma: results of the EORTC 18951 Biochemotherapy Trial. J Clin Oncol 25: 1562-1569, 2007.
14. Suzuki S, Toyabe S, Moroda T, et al: Circadian rhythm of leukocytes and lymphocyte subsets and its possible correlation with the function of the autonomic nervous system. Clin Exp Immunol 10: 500-508, 1997.
15. Mundy GR: Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2: 584-593, 2002.
16. Liotta LA and Kohn EC: The microenvironment of the tumour-host interface. Nature 411: 375-379, 2001.
17. Di carlo E, Forni G and Musiani P: Neutrophils in the antitumoral immune response. Chem Immunol Allergy 83: 182-203, 2003.
18. Schaider H, Oka M, Bogenrieder T, et al: Differential response of primary and metastatic melanomas to neutrophils attracted by IL-8. Int J Cancer 103: 335-343, 2003.
19. Shamamian P, Schwartz JD, Pocock BJ, Monea S, Whiting D, Marcus SG and Mignatti P: Activation of progelatinase A (MMP-2) by neutrophil elastase, cathepsin G, and proteinase-3: a role for inflammatory cells in tumor invasion and angiogenesis. J Cell Physiol 189: 197-206, 2001.
20. Scapini P, Nesi L, Morini M, et al: Generation of biologically active angiostatin kringle 1-3 by activated human neutrophils. J Immunol 168: 5798-5804, 2002.
21. Petrie HT, Klassen LW and Kay HD: Inhibition of human cytotoxic T lymphocyte activity in vitro by autologous peripheral blood granulocytes. J Immunol 134: 230-234, 1985.
22. El-Hag A and Clark RA: Immunosuppression by activated human neutrophils. Dependence on the myeloperoxidase system. J Immunol 139: 2406-2413, 1987.
23. Shau HY and Kim A: Suppression of lymphokine-activated killer induction by neutrophils. J Immunol 141: 4395-4402, 1988.
24. Kay HD and Smith DL: Regulation of human lymphocyte-mediated natural killer (NK) cell activity: inhibition in vitro by peripheral blood granulocytes. J Immunol 130: 475-483, 1983.